vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and Waterstone Financial, Inc. (WSBF). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $37.2M, roughly 1.3× Waterstone Financial, Inc.). On growth, Waterstone Financial, Inc. posted the faster year-over-year revenue change (16.7% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $23.0M). Over the past eight quarters, Waterstone Financial, Inc.'s revenue compounded faster (7.1% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
Waterstone Financial, Inc. is a U.S. bank holding company headquartered in Wisconsin. It offers retail and commercial banking services, residential mortgages, and wealth management solutions, primarily serving consumers and small to medium-sized businesses across the U.S. Midwest region.
IRWD vs WSBF — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $37.2M |
| Net Profit | $-2.3M | — |
| Gross Margin | — | — |
| Operating Margin | 14.3% | 27.0% |
| Net Margin | -4.8% | — |
| Revenue YoY | -47.3% | 16.7% |
| Net Profit YoY | -200.9% | — |
| EPS (diluted) | $0.01 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | $37.2M | ||
| Q3 25 | $122.1M | $37.0M | ||
| Q2 25 | $85.2M | $38.0M | ||
| Q1 25 | $41.1M | $29.7M | ||
| Q4 24 | $90.5M | $31.8M | ||
| Q3 24 | $91.6M | $34.1M | ||
| Q2 24 | $94.4M | $37.2M | ||
| Q1 24 | $74.9M | $32.4M |
| Q4 25 | $-2.3M | — | ||
| Q3 25 | $40.1M | $7.9M | ||
| Q2 25 | $23.6M | $7.7M | ||
| Q1 25 | $-37.4M | $3.0M | ||
| Q4 24 | $2.3M | — | ||
| Q3 24 | $3.6M | $4.7M | ||
| Q2 24 | $-860.0K | $5.7M | ||
| Q1 24 | $-4.2M | $3.0M |
| Q4 25 | 14.3% | 27.0% | ||
| Q3 25 | 61.8% | 26.6% | ||
| Q2 25 | 53.2% | 25.4% | ||
| Q1 25 | -70.7% | 13.1% | ||
| Q4 24 | 34.8% | 19.5% | ||
| Q3 24 | 28.0% | 17.3% | ||
| Q2 24 | 26.5% | 19.2% | ||
| Q1 24 | 14.7% | 14.7% |
| Q4 25 | -4.8% | — | ||
| Q3 25 | 32.8% | 21.4% | ||
| Q2 25 | 27.7% | 20.3% | ||
| Q1 25 | -90.9% | 10.2% | ||
| Q4 24 | 2.5% | — | ||
| Q3 24 | 4.0% | 13.9% | ||
| Q2 24 | -0.9% | 15.4% | ||
| Q1 24 | -5.6% | 9.4% |
| Q4 25 | $0.01 | $0.43 | ||
| Q3 25 | $0.23 | $0.45 | ||
| Q2 25 | $0.14 | $0.43 | ||
| Q1 25 | $-0.23 | $0.17 | ||
| Q4 24 | $0.03 | $0.28 | ||
| Q3 24 | $0.02 | $0.26 | ||
| Q2 24 | $-0.01 | $0.31 | ||
| Q1 24 | $-0.03 | $0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | — |
| Total DebtLower is stronger | — | $412.3M |
| Stockholders' EquityBook value | $-261.8M | $349.4M |
| Total Assets | $396.9M | $2.3B |
| Debt / EquityLower = less leverage | — | 1.18× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | — | ||
| Q3 25 | $140.4M | — | ||
| Q2 25 | $92.9M | — | ||
| Q1 25 | $108.5M | — | ||
| Q4 24 | $88.6M | — | ||
| Q3 24 | $88.2M | — | ||
| Q2 24 | $105.5M | — | ||
| Q1 24 | $121.5M | — |
| Q4 25 | — | $412.3M | ||
| Q3 25 | $199.5M | $469.1M | ||
| Q2 25 | $199.3M | $465.7M | ||
| Q1 25 | $199.2M | $395.9M | ||
| Q4 24 | $199.0M | $446.5M | ||
| Q3 24 | $198.8M | $560.1M | ||
| Q2 24 | $198.6M | $660.8M | ||
| Q1 24 | $398.3M | $634.2M |
| Q4 25 | $-261.8M | $349.4M | ||
| Q3 25 | $-264.2M | $345.5M | ||
| Q2 25 | $-308.2M | $341.5M | ||
| Q1 25 | $-334.1M | $341.4M | ||
| Q4 24 | $-301.3M | $339.1M | ||
| Q3 24 | $-311.3M | $342.0M | ||
| Q2 24 | $-321.7M | $334.9M | ||
| Q1 24 | $-330.5M | $338.0M |
| Q4 25 | $396.9M | $2.3B | ||
| Q3 25 | $396.1M | $2.3B | ||
| Q2 25 | $342.9M | $2.3B | ||
| Q1 25 | $327.2M | $2.2B | ||
| Q4 24 | $350.9M | $2.2B | ||
| Q3 24 | $389.5M | $2.2B | ||
| Q2 24 | $395.6M | $2.3B | ||
| Q1 24 | $438.8M | $2.2B |
| Q4 25 | — | 1.18× | ||
| Q3 25 | — | 1.36× | ||
| Q2 25 | — | 1.36× | ||
| Q1 25 | — | 1.16× | ||
| Q4 24 | — | 1.32× | ||
| Q3 24 | — | 1.64× | ||
| Q2 24 | — | 1.97× | ||
| Q1 24 | — | 1.88× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $24.2M |
| Free Cash FlowOCF − Capex | $74.6M | $23.0M |
| FCF MarginFCF / Revenue | 156.3% | 61.9% |
| Capex IntensityCapex / Revenue | 0.0% | 3.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | $43.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $24.2M | ||
| Q3 25 | $47.6M | $32.7M | ||
| Q2 25 | $-15.1M | $-38.4M | ||
| Q1 25 | $20.0M | $26.7M | ||
| Q4 24 | $15.2M | $48.1M | ||
| Q3 24 | $9.9M | $74.1M | ||
| Q2 24 | $33.5M | $-39.5M | ||
| Q1 24 | $45.0M | $-9.9M |
| Q4 25 | $74.6M | $23.0M | ||
| Q3 25 | $47.6M | $32.4M | ||
| Q2 25 | $-15.1M | $-38.5M | ||
| Q1 25 | $19.9M | $26.5M | ||
| Q4 24 | — | $47.0M | ||
| Q3 24 | $9.9M | $73.9M | ||
| Q2 24 | $33.4M | $-39.7M | ||
| Q1 24 | $44.9M | $-10.3M |
| Q4 25 | 156.3% | 61.9% | ||
| Q3 25 | 39.0% | 87.5% | ||
| Q2 25 | -17.7% | -101.2% | ||
| Q1 25 | 48.4% | 89.2% | ||
| Q4 24 | — | 147.5% | ||
| Q3 24 | 10.8% | 216.9% | ||
| Q2 24 | 35.4% | -106.7% | ||
| Q1 24 | 60.0% | -31.9% |
| Q4 25 | 0.0% | 3.1% | ||
| Q3 25 | 0.0% | 0.8% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.1% | 0.9% | ||
| Q4 24 | 0.0% | 3.5% | ||
| Q3 24 | 0.0% | 0.6% | ||
| Q2 24 | 0.1% | 0.4% | ||
| Q1 24 | 0.1% | 1.2% |
| Q4 25 | — | — | ||
| Q3 25 | 1.19× | 4.13× | ||
| Q2 25 | -0.64× | -4.98× | ||
| Q1 25 | — | 8.81× | ||
| Q4 24 | 6.74× | — | ||
| Q3 24 | 2.71× | 15.67× | ||
| Q2 24 | — | -6.92× | ||
| Q1 24 | — | -3.27× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
